EphA1 expression was not associated with either clinicopathological variables (data not shown) or patients’ survival in both subgroups (Figures 3 and4) except for a borderline association with tumor proliferative capacity in the subgroup of lung adenocarcinoma (p = 0.053). Here, EPHA1 is linked to neoplasm.